NEU 6.41% $15.27 neuren pharmaceuticals limited

What would you expect the company to say? They have maintained...

  1. 1,133 Posts.
    lightbulb Created with Sketch. 115
    What would you expect the company to say? They have maintained communication about results of trials, and the recent presentation gave a full summary of progress and inference about value. The fall in share price is surprising, if it’s due to manipulation in advance of a bid then they wouldn’t comment on that. Very possibly it has surprised them as much as anyone. My guess is that holders have seen the company focus on going for P3 and don’t like the timescales involved.
    It’s not good to see SP falls after such good news but the main concern should be inherent value. no problem there.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.